Metastatic Hormone Refractory Prostate Cancer

Also known as: Refractory, metastatic hormone-refractory Prostate cancer / Hormone-refractory prostate cancer metastatic / Metastasis from hormone-refractory prostate cancer (disorder)

DrugDrug NameDrug Description
DB01248DocetaxelA taxoid antineoplastic agent used in the treatment of various cancers, such as locally advanced or metastatic breast cancer, metastatic prostate cancer, gastric adenocarcinoma, and head and neck cancer.
DrugDrug NamePhaseStatusCount
DB05812Abiraterone1Active Not Recruiting1
DB08875Cabozantinib1Active Not Recruiting1
DB09035Nivolumab1Active Not Recruiting1
DB00635Prednisone1Active Not Recruiting1
DB01248Docetaxel2Completed1
DB03010Patupilone2Completed1
DB00635Prednisone2Completed1